계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Foldrx Pharmaceuticals
company
About
FoldRx Pharmaceuticals is focused on discovering and developing disease-modifying drug therapies for protein misfolding diseases.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $43M
- Industries
- Biotechnology,Genetics,Health Care,Medical
- Founded date
- Jan 1, 2003
- Number Of Employee
- 11 - 50
- Operating Status
- Active
FoldRx Pharmaceuticals, Inc. engages in the discovery and development of disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The companyТs pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, transthyretin-associated amyloidoses with polyneuropathy and TTR-associated amyloidoses with cardiomyopathy, and a discovery program in Parkinson's disease and cystic fibrosis. FoldRx Pharmaceuticals, Inc. was founded in 2003 and is based in Cambridge, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$72M
Foldrx Pharmaceuticals has raised a total of
$72M
in funding over 2 rounds. Their latest funding was raised on
Jun 15, 2010 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 15, 2010 | Series Unknown | $29M | 1 | — | — | Detail |
| May 30, 2006 | Series B | $43M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Foldrx Pharmaceuticals is funded by 2 investors.
TPG
and Original Investors
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
TPG
|
— | Series Unknown |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
